Primatene Mist is the only OTC inhaler approved by the FDA for mild asthma in people 12 and older. Primatene Mist uses epinephrine, while albuterol uses albuterol sulfate, and they have different side ...

Oct. 21, 2002 (Boston) — A combination of nebulized albuterol and magnesium is more effective than albuterol alone for children with mild to moderate asthma, according to a study presented at the ...

Please provide your email address to receive an email when new articles are posted on . BATURA showed a 47% reduction in severe exacerbation risk with albuterol budesonide vs. albuterol in patients ...

Mild asthma could be better treated with the recent approval of the combination of albuterol/budesonide. This is a real game changer. Why? The drug Airsupra, that is the combination of ...

As-needed use of a metered-dose inhaler with albuterol plus budesonide (Airsupra) lowered the risk of severe exacerbations compared with albuterol alone for people with normally mild asthma, the phase ...

Severe exacerbation occurred in 5.1% of patients taking albuterol/budesonide compared with 9.1% of patients taking albuterol alone in the on-treatment efficacy population. Albuterol/budesonide ...

Please provide your email address to receive an email when new articles are posted on . Patients had mild asthma and uncontrolled symptoms. Doses included an albuterol-budesonide combination or ...

Some people with asthma need to use multiple inhaled medicines to keep their symptoms under control. Some inhaled medicines can be used on a regular basis to manage symptoms. Other inhaled medicines, ...

Albuterol is a generic drug prescribed to treat and help prevent certain breathing problems in adults and some children. Albuterol comes as an aerosol that you inhale. The dosage can vary depending on ...

For many years, the standard treatment for asthma was an inhaler with a medication called albuterol. Only if that wasn’t enough would additional medicines be added. If symptoms became especially bad, ...

BRIDGEWATER, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced that the U.S. Food and Drug Administration (FDA) has ...